Price rise! Stop production! How to break the dilemma of API supply?

[China Pharmaceutical network exhibition report] to carry out an investigation on the shortage of APIs and the soaring price What's behind the rise in the price of APIs? The State Administration of market supervision has launched an operation against the soaring price of APIs all of the above are the titles of reports about monopoly and price rise of API industry in recent two weeks As the "chip" of finished drugs, the price of API has become a key factor affecting the market price of finished drugs Looking around the whole API market, it can be divided into exclusive use part and outsourcing market The exclusive use part refers to the API required by the pharmaceutical enterprises for their own production, and the outsourcing market refers to the pharmaceutical enterprises purchasing from the specialized API manufacturers According to the data, in the market of nearly 130 billion US dollars in 2015, the scale of exclusive API is 80 billion US dollars, and the scale of outsourcing API market is 50 billion US dollars Among them, the annual compound growth rate of outsourcing API market is 5%, far exceeding the annual compound growth rate of exclusive use part In 2017, with the gradual expansion of outsourcing API market, the annual compound growth rate of API Market in China reached about 13% Most of the small and medium-sized enterprises that are greatly affected by the rising price of raw materials need less raw materials and more popular varieties, so they mainly rely on outsourcing In the face of fluctuations in the price of raw materials, it is more necessary to expand the alternative suppliers of raw materials It is reported that the 81st apichina API meeting will be held in Nanjing on October 17 As the weathervane and barometer of China's API market, apichina API will also receive more attention during the period of drastic changes in the current API market, with nearly 1000 raw and auxiliary material enterprises participating in the exhibition According to the insiders, the price fluctuation of raw materials has become the top priority for pharmaceutical enterprises to increase the number of alternative raw material suppliers Nanjing API association has become a platform for pharmaceutical enterprises to meet and communicate with old suppliers and select new suppliers The author understands that in addition to the product exhibition, the Nanjing API Fair will also hold the "2018 China Chemical Pharmaceutical annual summit", "the 31st China API Market Information Conference", "the 10th China International Pharmaceutical Industry Environmental Protection Development Forum", "the joint review and approval seminar of the original and auxiliary packages", "the quality management seminar of the original and auxiliary package suppliers"“ Wait for more than 20 thematic meetings with rich contents On October 17-19, the 81st API China API API API API API will also hold china-pharm pharmaceutical equipment exhibition in cooperation with the international exchange center of the drug administration to jointly build an industry grand meeting to open up the whole pharmaceutical industry chain and the whole life cycle of drugs During the period of drastic changes in API industry, API China API API will continue to work together with China's pharmaceutical industry for 50 years to cope with the difficulties and open a new chapter in development API China API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API API!!! Since the API China API China API API API API API China API API China API API API has been held in 1968, it has gone through 50 years together with the Chinese pharmaceutical industry, becoming a professional platform for providing solutions for the whole industrial chain of the pharmaceutical industry, and a Flagship Exhibition for the exhibition of new products and technologies of the Chinese pharmaceutical industry The exhibition focuses on improving the overall level of production and R & D of Chinese pharmaceutical raw materials, intermediates, pharmaceutical packaging materials and pharmaceutical equipment enterprises, attracting 60000 pharmaceutical enterprises from more than 20 countries and regions to visit the exhibition Over 97% of China's top 100 pharmaceutical enterprises regard API China as a platform for purchasing raw materials, packaging and equipment China food and drug International Exchange Center, together with its 22nd China International Pharmaceutical (industry) exhibition and Technology Exchange Conference (china-pharm) and API China API API, jointly held in Nanjing in 2018, jointly built a pharmaceutical industry exhibition with a complete industrial chain At that time, more than 60000 elites focusing on R & D and production in the field of global medicine, health care products and cosmetics will gather in Nanjing, the ancient capital of the Six Dynasties, to share the huge market opportunities brought by the vigorous development of China's major health industry, to promote the transformation and upgrading of China's pharmaceutical industry, to achieve the goal of China's transformation from a pharmaceutical power to a pharmaceutical power, to build global pharmaceutical industry technology The platform for product, resource and information exchange helps realize the healthy Chinese dream as soon as possible.